Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3301923rdf:typepubmed:Citationlld:pubmed
pubmed-article:3301923lifeskim:mentionsumls-concept:C0040259lld:lifeskim
pubmed-article:3301923lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:3301923lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:3301923lifeskim:mentionsumls-concept:C0700355lld:lifeskim
pubmed-article:3301923lifeskim:mentionsumls-concept:C0086960lld:lifeskim
pubmed-article:3301923pubmed:issue1lld:pubmed
pubmed-article:3301923pubmed:dateCreated1987-9-9lld:pubmed
pubmed-article:3301923pubmed:abstractTextSixty-two patients with mycologically confirmed tinea pedis received two different treatment regimens of ketoconazole 2% cream on a randomized double-blind basis for 1 month with weekly evaluations. A 4-week posttreatment follow-up permitted an assessment of recurrence or improvement. After 1 month of treatment, 90% of the patients treated once daily responded clinically, in comparison with 83% of those treated twice daily. The cure rate was 63% for the once-daily and 60% for the twice-daily group. This rate substantially improved at follow-up (77% and 73%, respectively). One patient from each group discontinued therapy for an adverse reaction. On the basis of both clinical and mycologic assessments, topical treatment with ketoconazole 2% cream was effective as a once-daily therapy.lld:pubmed
pubmed-article:3301923pubmed:languageenglld:pubmed
pubmed-article:3301923pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3301923pubmed:citationSubsetIMlld:pubmed
pubmed-article:3301923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3301923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3301923pubmed:statusMEDLINElld:pubmed
pubmed-article:3301923pubmed:monthJullld:pubmed
pubmed-article:3301923pubmed:issn0190-9622lld:pubmed
pubmed-article:3301923pubmed:authorpubmed-author:GreerDDlld:pubmed
pubmed-article:3301923pubmed:authorpubmed-author:JollyH WHWlld:pubmed
pubmed-article:3301923pubmed:issnTypePrintlld:pubmed
pubmed-article:3301923pubmed:volume17lld:pubmed
pubmed-article:3301923pubmed:ownerNLMlld:pubmed
pubmed-article:3301923pubmed:authorsCompleteYlld:pubmed
pubmed-article:3301923pubmed:pagination53-6lld:pubmed
pubmed-article:3301923pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:3301923pubmed:meshHeadingpubmed-meshheading:3301923-...lld:pubmed
pubmed-article:3301923pubmed:meshHeadingpubmed-meshheading:3301923-...lld:pubmed
pubmed-article:3301923pubmed:meshHeadingpubmed-meshheading:3301923-...lld:pubmed
pubmed-article:3301923pubmed:meshHeadingpubmed-meshheading:3301923-...lld:pubmed
pubmed-article:3301923pubmed:meshHeadingpubmed-meshheading:3301923-...lld:pubmed
pubmed-article:3301923pubmed:meshHeadingpubmed-meshheading:3301923-...lld:pubmed
pubmed-article:3301923pubmed:meshHeadingpubmed-meshheading:3301923-...lld:pubmed
pubmed-article:3301923pubmed:meshHeadingpubmed-meshheading:3301923-...lld:pubmed
pubmed-article:3301923pubmed:meshHeadingpubmed-meshheading:3301923-...lld:pubmed
pubmed-article:3301923pubmed:meshHeadingpubmed-meshheading:3301923-...lld:pubmed
pubmed-article:3301923pubmed:year1987lld:pubmed
pubmed-article:3301923pubmed:articleTitleComparative trial of a two-dosage schedule of ketoconazole 2% cream for the treatment of tinea pedis.lld:pubmed
pubmed-article:3301923pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3301923pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:3301923pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:3301923pubmed:publicationTypeRandomized Controlled Triallld:pubmed